|
| |
Image Results
Loading...
Loading...
GenVec USA Pages on BioPortfolio:
BioPortfolio - GenVec
4 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation ...
http://www.bioportfolio.com/biocorporate/534-GenVec.html...
|
BioPortfolio Biotechnology BioNews : live article
Genphar, Inc. (USA) IV-214. GenVec, Inc. (USA) IV-216. GeoVax Labs, Inc. (USA) IV-222. Geron Corporation (USA) IV-224. GlaxoSmithKline PLC (UK) IV-228. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
BioPortfolio - GenVec - Profile
Department of Research, GenVec Inc, Gaithersburg, MD 20878, USA.- Cancer Gene Ther. ... GenVec, Inc. 65 West Watkins Mill Rd, Gaithersburg MD 20878, USA. ...
http://www.bioportfolio.com/biocorporate/534-GenVec.pdf...
|
|
Biotechnology News Orphan Medical Search
GenVec, Inc announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to TNFerade for the treatment of pancreatic cancer. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
BioPortfolio - GenVec, Inc. - FDA Grants Orphan Drug Designation ...
designation by the U.S. Food and Drug Administration (FDA) for its proposed use in the treatment of locally advanced pancreatic cancer. About GenVec ...
http://www.bioportfolio.com/news/FDA-Grants-Orphan-Drug-Desi...
|
BioPortfolio - GenVec, Inc. - GenVec Announces Third Quarter 2009 ...
GenVec will hold a conference call at 10:00 a.m. EST on Friday, ... To listen to the live conference call, please dial 888-679-8040 (U.S. or Canada) or ...
http://www.bioportfolio.com/news/GenVec-Announces-Third-Quar...
|
BioPortfolio - GenVec, Inc. - GenVec to Present at Merriman Curhan ...
GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and ... UK Tel: (+44) 1300 321501. USA Voicemail and Fax: (+1) 415 680 2472 ...
http://www.bioportfolio.com/news/GenVec-to-Present-at-Merrim...
|
BioPortfolio - BLD Science PGC Scientifics - Profile
implement and manage the U.S. specialty sales force for Qutenza(TM). -- Amy C. Cavers has joined. NeurogesX as. GenVec Signs New · Contract to Support ...
http://www.bioportfolio.com/biocorporate/28073-BLD+Science+P...
|
BioPortfolio - CIDtech Research Incorporated - Profile
PR-USA.net: Nov 8 2009 12:38AM Matching: research ... Cancer Gene Therapy: GenVec, Inc., Department of Research publishes research in cancer gene ...
http://www.bioportfolio.com/biocorporate/2760-CIDtech%25252B...
|
BioPortfolio - Plant Transpiration
Department of Horticulture, Clemson University, Clemson, SC 29634, USA. ... GenVec Signs New Contract to Support HIV and Influenza Vaccine Development ...
http://www.bioportfolio.com/indepth/Plant_Transpiration.html...
| Results from other life science and pharmaceutical sites:
BioSpace - GenVec Inc. News, Search Jobs, Events
GenVec Inc. 65 West Watkins Mill Road Gaithersburg Maryland 20878 U.S.A. ... GenVec Inc. (GNVC) Announces Registered Offering of $6 Million in Common Stock
...
http://www.biospace.com/company_profile.aspx?CompanyId=2145...
|
Molecular Therapy - Abstract of article: Repeat Administration of ...
Correspondence: Lisa Wei, Director, Pre-Clinical Sciences, GenVec, Inc., 65 West Watkins Mill Road, Gaithersburg, Maryland 20878, USA. E-mail: lwei@genvec. ...
http://www.nature.com/mt/journal/vaop/ncurrent/abs/mt2008124...
|
BioSpace - Diacrin, Inc. (Merged With Genvec) News, Search Jobs ...
Diacrin, Inc. (Merged With Genvec) Press releases archived for reference only. ... Charlestown Massachusetts 02129 U.S.A.. Phone: 617-242-9100 Fax: ...
http://www.biospace.com/company_profile.aspx?CompanyId=2907...
|
Malaria Vaccine Initiative :
31 Mar 2004 ... GenVec, U.S. Naval Medical Research Center and PATH'S Malaria Vaccine Initiative Partner to Expand Malaria Vaccine Efforts ...
http://www.malariavaccine.org/files/040331/310304_GenVec-MVI...
|
Cancer Gene Therapy - Abstract of article: Combination of human ...
Correspondence: Dr LL Wei, Department of Research, GenVec Inc, 65 West Watkins Mill Road, Gaithersburg, MD 20878, USA. E-mail: lwei@genvec.com ...
http://www.nature.com/cgt/journal/v16/n11/abs/cgt200932a.htm...
|
Angiogenic gene therapy strategies for the treatment of ...
GenVec Inc, Gaithersburg, MD 20878, USA. hrasmussen@genvec.com. Coronary artery disease (CAD) and peripheral vascular disease (PVD) are significant medical ...
http://www.ncbi.nlm.nih.gov/pubmed/12435049...
|
No Slide Title
Genvec (USA). - Aventis (FR). - Schering AG (GER). - ML Laboratories (UK). - Merck KGaA (GER). - Oxford Biomed.(UK). - Selective Genetics (USA) ...
http://www.dsm.com/en_US/downloads/invest/DSM_Crucell_announ...
|
TNFerade Biologic: Preclinical toxicology of a novel adenovector ...
Correspondence to: Dr Henrik Rasmussen, Clinical Research and Regulatory Affairs , GenVec Inc., 65 West Watkins Mill Road, Gaithersburg, MD 20878, USA. ...
http://www.nature.com/cgt/journal/v9/n11/abs/7700518a.html...
|
Targeted adenovirus-mediated gene delivery to T cells via CD3.
GenVec, Inc., Rockville, Maryland 20852-1709, USA. wickham@genvec.com. Small right arrow pointing to: This article has been cited by other articles in PMC.
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC192116/...
|
Molecular Therapy - Abstract of article: Persistent Expression of ...
1GenVec, Inc. Research Department, Gaithersburg, Maryland, USA; 2Retina Division , Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA ...
http://www.nature.com/mt/journal/v16/n12/abs/mt2008211a.html...
|
|
